Just in case any of my writing-oriented readers aren't already aware from other sources, I thought this might be worth providing some extra signal boost for ( Read more... )

This was bad enough. The idea that a major publisher of peer-reviewed science journals would publish a fake medical 'journal' in exchange for cash from a drug company is repulsive at best[0]. But they didn't stop at one. So far as anyone knows, this is limited to Elsevier's Australian division[1][2], but do you know what? I don't care. Even if ( Read more... )